Analysis the cost of chronic obstructive pulmonary disease in Russian Federation

Objective: to evaluate the economic burden of chronic obstructive pulmonary disease (COPD) in Russian Federation. Methods: This paper analyzes the existing evidence base for assessing the value of COPD. The estimation of the economic burden of COPD in Russia using clinical-economic analysis — the «c...

Full description

Bibliographic Details
Main Author: I. S. Krysanov
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-06-01
Series:Качественная клиническая практика
Subjects:
Online Access:https://www.clinvest.ru/jour/article/view/204
_version_ 1797262053356863488
author I. S. Krysanov
author_facet I. S. Krysanov
author_sort I. S. Krysanov
collection DOAJ
description Objective: to evaluate the economic burden of chronic obstructive pulmonary disease (COPD) in Russian Federation. Methods: This paper analyzes the existing evidence base for assessing the value of COPD. The estimation of the economic burden of COPD in Russia using clinical-economic analysis — the «cost of illness» (COI). The study took into account only the direct costs of the state, there were two variants of calculations using statistics in 2007 (according to some indicators more recent data are not available) and extrapolated data based on the incidence in 2012. Results: The economic burden of COPD in Russian Federation (direct costs excluding the costs of drug therapy) for the first version (2007 statistics) calculations was 54.6 billion rubles for the second option (statistics extrapolated to 2012) calculations — 61.6 billion rubles. Structure of direct expenses of the state for the treatment of COPD in Russia was as follows — 77% of hospitalization costs, 21% — the costs of outpatient care, 2% of the cost — emergency medical care. The largest share of costs associated with COPD exacerbation. Conclusion: At the present stage of COPD is an important cause of morbidity and mortality worldwide, resulting in significant economic and social damage, the level of which increases. Prevalence, morbidity and mortality due to this disease varies greatly in different countries and subpopulations within a country and usually depend on the prevalence of smoking. Correct interpretation of the concept of COPD, use of common diagnostic criteria, standardization conducted epidemiological and economic studies are essential estimate of the true damage this disease.
first_indexed 2024-04-24T23:51:00Z
format Article
id doaj.art-9cbc9274a0ef434ab3de95ccccb1aced
institution Directory Open Access Journal
issn 2588-0519
2618-8473
language Russian
last_indexed 2024-04-24T23:51:00Z
publishDate 2018-06-01
publisher Izdatelstvo OKI
record_format Article
series Качественная клиническая практика
spelling doaj.art-9cbc9274a0ef434ab3de95ccccb1aced2024-03-14T18:09:06ZrusIzdatelstvo OKIКачественная клиническая практика2588-05192618-84732018-06-01025156203Analysis the cost of chronic obstructive pulmonary disease in Russian FederationI. S. Krysanov0ГБОУ ВПО Медицинский институт усовершенствования врачей МГУППObjective: to evaluate the economic burden of chronic obstructive pulmonary disease (COPD) in Russian Federation. Methods: This paper analyzes the existing evidence base for assessing the value of COPD. The estimation of the economic burden of COPD in Russia using clinical-economic analysis — the «cost of illness» (COI). The study took into account only the direct costs of the state, there were two variants of calculations using statistics in 2007 (according to some indicators more recent data are not available) and extrapolated data based on the incidence in 2012. Results: The economic burden of COPD in Russian Federation (direct costs excluding the costs of drug therapy) for the first version (2007 statistics) calculations was 54.6 billion rubles for the second option (statistics extrapolated to 2012) calculations — 61.6 billion rubles. Structure of direct expenses of the state for the treatment of COPD in Russia was as follows — 77% of hospitalization costs, 21% — the costs of outpatient care, 2% of the cost — emergency medical care. The largest share of costs associated with COPD exacerbation. Conclusion: At the present stage of COPD is an important cause of morbidity and mortality worldwide, resulting in significant economic and social damage, the level of which increases. Prevalence, morbidity and mortality due to this disease varies greatly in different countries and subpopulations within a country and usually depend on the prevalence of smoking. Correct interpretation of the concept of COPD, use of common diagnostic criteria, standardization conducted epidemiological and economic studies are essential estimate of the true damage this disease.https://www.clinvest.ru/jour/article/view/204фармакоэкономикаанализ стоимости болезнибремя заболеванияхроническая обструктивная болезнь лёгких
spellingShingle I. S. Krysanov
Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
Качественная клиническая практика
фармакоэкономика
анализ стоимости болезни
бремя заболевания
хроническая обструктивная болезнь лёгких
title Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
title_full Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
title_fullStr Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
title_full_unstemmed Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
title_short Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
title_sort analysis the cost of chronic obstructive pulmonary disease in russian federation
topic фармакоэкономика
анализ стоимости болезни
бремя заболевания
хроническая обструктивная болезнь лёгких
url https://www.clinvest.ru/jour/article/view/204
work_keys_str_mv AT iskrysanov analysisthecostofchronicobstructivepulmonarydiseaseinrussianfederation